MEDIFAST INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Medifast Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2024.
  • Medifast Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.45M, a 2.39% decline year-over-year.
  • Medifast Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.69M, a 7.31% increase year-over-year.
  • Medifast Inc annual Share-based Payment Arrangement, Expense for 2023 was $8.19M, a 25.9% decline from 2022.
  • Medifast Inc annual Share-based Payment Arrangement, Expense for 2022 was $11.1M, a 11.6% increase from 2021.
  • Medifast Inc annual Share-based Payment Arrangement, Expense for 2021 was $9.9M, a 45.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.69M $2.45M -$60K -2.39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $9.75M $2.17M +$1.57M +258% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $8.19M $2.39M -$557K -18.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $8.75M $2.68M -$288K -9.72% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $9.03M $2.51M -$351K -12.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $9.38M $606K -$1.67M -73.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $11.1M $2.95M -$288K -8.89% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $11.3M $2.96M +$694K +30.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $10.6M $2.87M +$667K +30.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $9.98M $2.28M +$77K +3.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-01
Q4 2021 $9.9M $3.24M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $2.27M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.